title: The clinical relevance of cell-based therapy for the treatment of stress urinary incontinence.
abstract: Stress urinary incontinence is a common disorder affecting the quality of life for millions of women worldwide. Effective surgical procedures involving synthetic permanent meshes exist, but significant short- and long-term complications occur. Cell-based therapy using autologous stem cells or progenitor cells presents an alternative approach, which aims at repairing the anatomical components of the urethral continence mechanism. In vitro expanded progenitor cells isolated from muscle biopsies have been most intensely investigated, and both preclinical trials and a few clinical trials have provided proof of concept for the idea. An initial enthusiasm caused by positive results from early clinical trials has been dampened by the recognition of scientific irregularities. At the same time, the safety issue for cell-based therapy has been highlighted by the appearance of new and comprehensive regulatory demands. The influence on the cost effectiveness, the clinical relevance and the future perspectives of the present clinical approach are discussed.
authors.affiliation: Department of Obstetrics and Gynecology, Copenhagen University Hospital, Herlev, Denmark. s.gras@dadlnet.dk
authors.forename: Søren
authors.initials: S
authors.lastname: Gräs
authors.forename: Gunnar
authors.initials: G
authors.lastname: Lose
mesh_terms: D000818:Animals; D064987:Cell- and Tissue-Based Therapy; D003362:Cost-Benefit Analysis; D005260:Female; D006801:Humans; D033581:Stem Cell Transplantation; D014550:Urinary Incontinence, Stress / Q000191:economics / Q000628:therapy*